Patients with autism spectrum disorders display reproducible functional connectivity alterations

Štefan Holiga(Roche (Switzerland)), Juergen Dukart(Roche (Switzerland)), Alessandro Bertolino(University of Bari Aldo Moro), Jan K. Buitelaar(Radboud University Nijmegen), Manuel Bouvard(Centre Hospitalier Charles Perrens), G.D. Honey(Roche (Switzerland)), Richard Delorme(Centre National de la Recherche Scientifique), Federico Bolognani(Roche (Switzerland)), Tony Charman(University College London), Anita Beggiato(Institut Pasteur), Mireille Caralp(Inserm), Marion Leboyer(Inserm), Annika Rausch(Radboud University Nijmegen), Declan Murphy(NeuroDevelopment Center), Pilar Garcés(Roche (Switzerland)), Julian Tillmann(King's College London), Christopher H. Chatham(Brown University), Will Spooren(Roche (Switzerland)), Xavier Liogier D’ardhuy(Roche (Switzerland)), Myriam Ly‐Le Moal(Roche (France)), Sonia Guéguen(Inserm), Marianne Oldehinkel(Radboud University Nijmegen), Christian F. Beckmann(Radboud University Nijmegen), Marc-Antoine d’Albis(Inserm), Christian Czech(Pfizer (France)), Carsten Bours(Radboud University Nijmegen), Charles Laidi(Inserm), Eva Loth(King's College London), Anouck Amestoy(Centre Hospitalier Charles Perrens), Isabelle Scheid(Inserm), Alexandru Gaman(Inserm), Jeff Sevigny(Ovid Therapeutics (United States)), Joerg F. Hipp(Roche (Switzerland)), Céline Bouquet(Roche (Switzerland)), Josselin Houenou(Inserm)
Science Translational Medicine
February 27, 2019
Cited by 180


Related Papers